@article {765,
	title = {Intravitreal bevacizumab for peripapillary choroidal neovascular membranes.},
	journal = {Arch Ophthalmol},
	volume = {130},
	year = {2012},
	month = {2012 Aug},
	pages = {1073-5},
	keywords = {Adult, Aged, Aged, 80 and over, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Bevacizumab, Choroidal Neovascularization, Female, Fluorescein Angiography, Humans, Intravitreal Injections, Macular Degeneration, Male, Middle Aged, Retreatment, Subretinal Fluid, Tomography, Optical Coherence, Treatment Outcome, Vascular Endothelial Growth Factor A, Visual Acuity},
	issn = {1538-3601},
	doi = {10.1001/archophthalmol.2012.465},
	author = {Davis, Andrew S and Folk, James C and Russell, Stephen R and Sohn, Elliott H and Sohn, Elliot H and Boldt, H Culver and Stone, Edwin M and Mahajan, Vinit B}
}
